Loading...
Daré Bioscience, Inc.
DARE•NASDAQ
Healthcare
Biotechnology
$2.52
$0.13(5.44%)
Daré Bioscience, Inc. (DARE) Financial Performance & Statements
Review Daré Bioscience, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-99.65%
↓ 99.65%
Operating Income Growth
23.96%
↑ 23.96%
Net Income Growth
86.56%
↑ 86.56%
Operating Cash Flow Growth
113.88%
↑ 113.88%
Operating Margin
-224.59%
↓ 224.59%
Gross Margin
-0.25%
↓ 0.25%
Net Profit Margin
-17.11%
↓ 17.11%
ROE
46.61%
↑ 46.61%
ROIC
856.71%
↑ 856.71%
Daré Bioscience, Inc. (DARE) Financial Statements
Explore quarterly and annual reports for Daré Bioscience, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | -$63647.00 | $41691.00 | $22438.00 | $9302.00 |
| Cost of Revenue | $0.00 | $0.00 | $25000.00 | $10778.00 |
| Gross Profit | -$63647.00 | $41691.00 | -$2562.00 | -$1476.00 |
| Gross Profit Ratio | $1.00 | $1.00 | -$0.11 | -$0.16 |
| R&D Expenses | $3.31M | $2.66M | $4.91M | $3.33M |
| SG&A Expenses | $1.92M | $2.04M | $2.47M | $2.66M |
| Operating Expenses | $5.32M | $4.72M | $7.38M | $5.99M |
| Total Costs & Expenses | $5.32M | $4.72M | $7.38M | $6.00M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $7674.00 |
| Depreciation & Amortization | $6368.00 | $9742.00 | $15437.00 | $10778.00 |
| EBITDA | -$5.38M | -$4.67M | -$7.34M | -$6.01M |
| EBITDA Ratio | $84.56 | -$112.05 | -$327.30 | -$646.28 |
| Operating Income | -$5.39M | -$4.68M | -$7.36M | -$5.99M |
| Operating Income Ratio | $84.66 | -$112.29 | -$327.99 | -$643.93 |
| Other Income/Expenses (Net) | -$118201.00 | -$21152.00 | $20.27M | -$732883.00 |
| Income Before Tax | -$5.51M | -$4.70M | $12.91M | -$6.76M |
| Income Before Tax Ratio | $86.51 | -$112.79 | $575.39 | -$726.23 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $2.00 |
| Net Income | -$5.51M | -$4.70M | $12.91M | -$6.76M |
| Net Income Ratio | $86.51 | -$112.79 | $575.39 | -$726.23 |
| EPS | -$0.65 | -$0.55 | $1.53 | -$0.81 |
| Diluted EPS | -$0.65 | -$0.55 | $1.52 | -$0.81 |
| Weighted Avg Shares Outstanding | $8.50M | $8.53M | $8.41M | $8.38M |
| Weighted Avg Shares Outstanding (Diluted) | $8.50M | $8.53M | $8.48M | $8.38M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan